Hepatocyte growth factor is required for mesenchymal stromal cell protection against bleomycin-induced pulmonary fibrosis

Stem Cells Translational Medicine

Volumn 5, Issue 10, 2016, Pages 1307-1318

  Cahill, Emer F ^a   Kennelly, Helen ^a   Carty, Fiona ^a   Mahon, Bernard P ^a   English, Karen ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Antiapoptotic; Fibrosis; Hepatocyte growth factor; Mesenchymal stromal cell

Indexed keywords

BLEOMYCIN; CYCLOOXYGENASE 2; CYTOPROTECTIVE AGENT; DNA NUCLEOTIDYLEXOTRANSFERASE; PHOSPHATE BUFFERED SALINE; SCATTER FACTOR; SHORT HAIRPIN RNA; ANTINEOPLASTIC ANTIBIOTIC;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; LUNG FIBROSIS; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE REPAIR; WOUND CLOSURE; WOUND HEALING; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DISEASE MODEL; FIBROSING ALVEOLITIS; GENE SILENCING; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TUNEL ASSAY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BLEOMYCIN; DISEASE MODELS, ANIMAL; FEMALE; GENE KNOCKDOWN TECHNIQUES; HEPATOCYTE GROWTH FACTOR; IDIOPATHIC PULMONARY FIBROSIS; IN SITU NICK-END LABELING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION;

EID: 84988569326     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2015-0337     Document Type: Article

References (64)

1. Wilson MS, Wynn TA. Pulmonary fibrosis: Pathogenesis, etiology and regulation. Mucosal Immunol 2009; 2: 103-121.
2. Wick G, Grundtman C, Mayerl C et al. The immunology of fibrosis. Annu Rev Immunol 2013; 31: 107-135.
3. Robson MC, Steed DL, Franz MG. Wound healing: Biologic features and approaches to maximize healing trajectories. Curr Probl Surg 2001; 38: 72-140.
4. Lown JW, Sim SK. The mechanism of the bleomycin-induced cleavage of DNA. Biochem Biophys Res Commun 1977; 77: 1150-1157.
5. Cahill EF, Tobin LM, Carty F et al. Jagged-1 is required for the expansion of CD4+ CD25+ FoxP3+ regulatory T cells and tolerogenic dendritic cells by murine mesenchymal stromal cells. Stem Cell Res Ther 2015; 6: 19.
6. English K. Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol 2013; 91: 19-26.
7. Tobin LM, Healy ME, English K et al. Human mesenchymal stem cells suppress donor CD4(+) T cell proliferation and reduce pathology in a humanized mouse model of acute graftversus- host disease. Clin Exp Immunol 2013; 172: 333-348.
8. Noone C, Kihm A, English K et al. IFN-g stimulated human umbilical-tissue-derived cells potently suppress NK activation and resist NK-mediated cytotoxicity in vitro. Stem Cells Dev 2013; 22: 3003-3014.
9. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006; 98: 1076-1084.
10. Chen L, Tredget EE,WuPY et al. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 2008; 3: e1886.
11. Ortiz LA, Gambelli F, McBride C et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003; 100: 8407-8411.
12. Rojas M, Xu J, Woods CR et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung.AmJ Respir Cell Mol Biol 2005; 33: 145-152.
13. Ortiz LA, DutreilM, FattmanCet al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stemcells during lung injury. Proc Natl Acad Sci USA 2007; 104: 11002-11007.
14. Maher TM, Evans IC, Bottoms SE et al. Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010; 182: 73-82.
15. Mizuno S, Matsumoto K, Li MY et al. HGF reduces advancing lung fibrosis in mice: A potential role for MMP-dependent myofibroblast apoptosis. FASEB J 2005; 19: 580-582.
16. Németh K, Leelahavanichkul A, Yuen PS et al. Bonemarrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15: 42-49.
17. Kavanagh H, Mahon BP. Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells. Allergy 2011; 66: 523-531.
18. Jun D, Garat C, West J et al. The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation. Stem Cells 2011; 29: 725-735.
19. Weiss DJ, Casaburi R, Flannery R et al. A placebo-controlled, randomized trial of mesenchymal stemcells inCOPD.Chest2013; 143: 1590-1598.
20. Matsumoto K, Nakamura T. Roles of HGF as a pleiotropic factor in organ regeneration. EXS 1993; 65: 225-249.
21. Yaekashiwa M, Nakayama S, Ohnuma K et al. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am J Respir Crit Care Med 1997; 156: 1937-1944.
22. Dohi M, Hasegawa T, Yamamoto K et al. Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis. Am J Respir Crit Care Med 2000; 162: 2302-2307.
23. Ashcroft T, Simpson JM, Timbrell V. Simple methodof estimating severity ofpulmonary fibrosis onanumerical scale. JClinPathol1988; 41: 467-470.
24. Ryan JM, Barry F, Murphy JM et al. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 2007; 149: 353-363.
25. Cilli F, KhanM,Fu F et al. Prostaglandin E2 affects proliferation and collagen synthesis by human patellar tendon fibroblasts. Clin J Sport Med 2004; 14: 232-236.
26. Lama V, Moore BB, Christensen P et al. Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent. Am J Respir Cell Mol Biol 2002; 27: 752-758.
27. Moore BB, Peters-GoldenM, Christensen PJ et al. Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2. Am J Physiol Lung Cell Mol Physiol 2003; 284: L342-L349.
28. English K, Barry FP, Field-Corbett CP et al. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol Lett 2007; 110: 91-100.
29. Roy SG, Nozaki Y, Phan SH. Regulation of alpha-smooth muscle actin gene expression in myofibroblast differentiation fromrat lung fibroblasts. Int J Biochem Cell Biol 2001; 33: 723-734.
30. Henkels KM, Turchi JJ. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines. Cancer Res 1999; 59: 3077-3083.
31. Gao J, Dennis JE, Muzic RF et al. The dynamic in vivo distribution of bone marrowderived mesenchymal stem cells after infusion. Cells Tissues Organs 2001; 169: 12-20.
32. KottonDN, Fabian AJ,Mulligan RC. Failure of bone marrowto reconstitute lung epithelium. Am J Respir Cell Mol Biol 2005; 33: 328-334.
33. Phinney DG, Prockop DJ. Concise review: Mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007; 25: 2896-2902.
34. Duffield JS, Bonventre JV. Kidney tubular epitheliumis restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int 2005; 68: 1956-1961.
35. English K, Mahon BP, Wood KJ. Mesenchymal stromal cells: Role in tissue repair, drug discovery and immune modulation. Curr Drug Deliv 2014; 11: 561-571.
36. Smith AN, Willis E, Chan VT et al. Mesenchymal stem cells induce dermal fibroblast responses to injury. Exp Cell Res 2010; 316: 48-54.
37. Lan YW, Choo KB, Chen CM et al. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis. Stem Cell Res Ther 2015; 6: 97.
38. Akram KM, Samad S, Spiteri MA et al. Mesenchymal stemcells promote alveolar epithelial cell woundrepair invitro throughdistinctmigratory and paracrine mechanisms. Respir Res 2013; 14: 9.
39. Yew TL, Hung YT, Li HY et al. Enhancement of wound healing by human multipotent stromal cell conditioned medium: The paracrine factors and p38 MAPK activation. Cell Transplant 2011; 20: 693-706.
40. Broekman W, Amatngalim GD, de Mooij-Eijk Y et al. TNF-a and IL-1b-activated humanmesenchymal stromal cells increase airway epithelial wound healing in vitro via activation of the epidermal growth factor receptor. Respir Res 2016; 17: 3.
41. Shen Q,Chen B, Xiao Z et al. Paracrine factors from mesenchymal stem cells attenuate epithelial injury and lung fibrosis. Mol Med Rep 2015; 11: 2831-2837.
42. Boyle JE, Lindroos PM, Rice AB et al. Prostaglandin-E2 counteracts interleukin-1betastimulatedupregulationofplatelet- derivedgrowth factor alpha-receptor on rat pulmonary myofibroblasts. AmJ Respir CellMol Biol 1999; 20: 433-440.
43. PanT,MasonRJ,Westcott JYet al.Rat alveolar type II cells inhibit lung fibroblast proliferation in vitro.AmJRespirCellMol Biol 2001; 25: 353-361.
44. Shyamsundar M, McAuley DF, Ingram RJ et al. Keratinocyte growth factor promotes epithelial survival and resolution in a human model of lung injury. Am J Respir Crit Care Med 2014; 189: 1520-1529.
45. PuddicombeSM,Polosa R, RichterAet al. Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J 2000; 14: 1362-1374.
46. Brown KR, England KM, Goss KL et al. VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. Am J Physiol Lung Cell Mol Physiol 2001; 281: L1001-L1010.
47. Lee JW, Krasnodembskaya A, McKenna DH et al. Therapeutic effects of human mesenchymal stem cells in ex vivohumanlungs injured with live bacteria. Am J Respir Crit Care Med 2013; 187: 751-760.
48. Curley GF, Hayes M, Ansari B et al. Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax 2012; 67: 496-501.
49. Guan XJ, Song L,Han FF et al.Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary function partly via VEGF-VEGF receptors. J Cell Biochem 2013; 114: 323-335.
50. Gazdhar A, Fachinger P, van Leer C et al. Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2007; 292: L529-L536.
51. Watanabe M, Ebina M, Orson FM et al. Hepatocyte growth factor gene transfer to alveolar septa for effective suppression of lung fibrosis. Mol Ther 2005; 12: 58-67.
52. Weil BR, Markel TA, Herrmann JL et al. Mesenchymal stem cells enhance the viability and proliferation of human fetal intestinal epithelial cells following hypoxic injury via paracrine mechanisms. Surgery 2009; 146: 190-197.
53. Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008; 294: L152-L160.
54. Moeller A, Ask K, Warburton D et al. The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 2008; 40: 362-382.
55. Dong LH, Jiang YY, Liu YJ et al. The antifibrotic effects of mesenchymal stem cells on irradiated lungs via stimulating endogenous secretion of HGF and PGE2. Sci Rep 2015; 5: 8713.
56. Sabry MM, Elkalawy SA, Abo-Elnour RK et al. Histolgical and immunohistochemical study on the effect of stem cell therapy on bleomycin induced pulmonary fibrosis in albino rat. Int J Stem Cells 2014; 7: 33-42.
57. Moodley Y, Atienza D, Manuelpillai U et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol 2009; 175: 303-313.
58. Ono M, Ohkouchi S, Kanehira M et al. Mesenchymal stem cells correct inappropriate epithelial-mesenchyme relation in pulmonary fibrosis using stanniocalcin-1. Mol Ther 2015; 23: 549-560.
59. Lee YJ, Moon C, Lee SH et al. Apoptotic cell instillation after bleomycin attenuates lung injury through hepatocyte growth factor induction. Eur Respir J 2012; 40: 424-435.
60. Yoon YS, Lee YJ, Choi JY et al. Coordinated induction of cyclooxygenase-2/prostaglandin E2 and hepatocyte growth factor by apoptotic cells prevents lung fibrosis. J Leukoc Biol 2013; 94: 1037-1049.
61. Cargnoni A, Piccinelli EC, Ressel L et al. Conditioned medium from amniotic membranederived cells prevents lung fibrosis and preserves blood gas exchanges in bleomycin-injured micespecificity of the effects and insights into possible mechanisms. Cytotherapy 2014; 16: 17-32.
62. Bustos ML, Huleihel L, Meyer EM et al. Activation of human mesenchymal stem cells impacts their therapeutic abilities in lung injury by increasing interleukin (IL)-10 and IL-1RN levels. Stem Cells Transl Med 2013; 2: 884-895.
63. Gazdhar A, Grad I,Tamò L et al. The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor. Stem Cell Res Ther 2014; 5: 123.
64. Gazdhar A, Susuri N, Hostettler K et al. HGF expressing stem cells in usual interstitial pneumonia originate from the bone marrow and are antifibrotic. PLoS One 2013; 8: e65453.